Superior benefits of sodium‐glucose co‐transporter‐2 inhibitors compared with dipeptidyl peptidase‐4 inhibitors for diabetic kidney disease: A cohort study
Year: 2024
Type: article
Study design: Observational Study
Source: Diabetes Obesity and Metabolism
DOI: 10.1111/dom.15998
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4403515818
